Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $1.76 billion. The enterprise value is $1.60 billion.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTA has 133.62 million shares outstanding. The number of shares has increased by 26.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 133.62M |
| Shares Change (YoY) | +26.02% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 0.68% |
| Owned by Institutions (%) | 58.97% |
| Float | 85.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 103.77 |
| Forward PS | n/a |
| PB Ratio | 4.38 |
| P/TBV Ratio | 4.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 106.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.37, with a Debt / Equity ratio of 0.31.
| Current Ratio | 14.37 |
| Quick Ratio | 13.93 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.75 |
Financial Efficiency
Return on equity (ROE) is -74.44% and return on invested capital (ROIC) is -30.38%.
| Return on Equity (ROE) | -74.44% |
| Return on Assets (ROA) | -28.58% |
| Return on Invested Capital (ROIC) | -30.38% |
| Return on Capital Employed (ROCE) | -38.87% |
| Revenue Per Employee | $194,805 |
| Profits Per Employee | -$2.91M |
| Employee Count | 77 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CNTA has paid $3.76 million in taxes.
| Income Tax | 3.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.83% in the last 52 weeks. The beta is 1.49, so CNTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +46.83% |
| 50-Day Moving Average | 12.81 |
| 200-Day Moving Average | 15.25 |
| Relative Strength Index (RSI) | 52.98 |
| Average Volume (20 Days) | 1,209,944 |
Short Selling Information
| Short Interest | 4.47M |
| Short Previous Month | 5.26M |
| Short % of Shares Out | 3.94% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.45 |
Income Statement
In the last 12 months, CNTA had revenue of $15.00 million and -$223.85 million in losses. Loss per share was -$1.82.
| Revenue | 15.00M |
| Gross Profit | 15.00M |
| Operating Income | -195.74M |
| Pretax Income | -163.67M |
| Net Income | -223.85M |
| EBITDA | -195.42M |
| EBIT | -195.74M |
| Loss Per Share | -$1.82 |
Full Income StatementBalance Sheet
The company has $284.51 million in cash and $118.00 million in debt, giving a net cash position of $166.51 million or $1.25 per share.
| Cash & Cash Equivalents | 284.51M |
| Total Debt | 118.00M |
| Net Cash | 166.51M |
| Net Cash Per Share | $1.25 |
| Equity (Book Value) | 386.25M |
| Book Value Per Share | 2.89 |
| Working Capital | 323.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$162.02 million and capital expenditures -$34,000, giving a free cash flow of -$162.05 million.
| Operating Cash Flow | -162.02M |
| Capital Expenditures | -34,000 |
| Free Cash Flow | -162.05M |
| FCF Per Share | -$1.21 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,304.95% |
| Pretax Margin | -1,467.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.02% |
| Shareholder Yield | -26.02% |
| Earnings Yield | -12.69% |
| FCF Yield | -9.19% |
Analyst Forecast
The average price target for CNTA is $28.78, which is 118.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.78 |
| Price Target Difference | 118.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CNTA has an Altman Z-Score of 4.01 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.01 |
| Piotroski F-Score | 3 |